Research graph
References from Recent advances in antioxidant nanozymes for the treatment of inflammatory bowel disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Crohn's disease
10.1016/s0140-6736(23)02586-2 · 2024 · External reference
Ulcerative colitis
10.1016/s0140-6736(16)32126-2 · 2017 · External reference
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
10.1016/s0140-6736(17)32448-0 · 2017 · External reference
Global evolution of inflammatory bowel disease across epidemiologic stages
10.1038/s41586-025-08940-0 · 2025 · External reference
The burden of inflammatory bowel disease in Europe in 2020
10.1093/ecco-jcc/jjab029 · 2021 · External reference
Epidemiological, clinical, patient-reported and economic burden of inflammatory bowel disease (ulcerative colitis and Crohn's disease) in Spain: a systematic review
10.1007/s12325-023-02473-6 · 2023 · External reference
CD-MOF based pH/ROS sensitive 5-ASA delivery system for ulcerative colitis therapy
10.1002/adhm.202501160 · 2025 · External reference
Patients with inflammatory bowel disease are at increased risk for complications of herpes zoster
10.1016/j.cgh.2024.09.022 · 2025 · External reference
Recent advances in the treatment of IBD: targets, mechanisms and related therapies
10.1016/j.cytogfr.2023.07.001 · 2023 · External reference
Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response
10.1038/s41575-025-01063-x · 2025 · External reference
Oral administration of TNF-α-modulating probiotics integrated by dual-layered microcapsule for effective treatment of inflammatory bowel disease
10.1016/j.cej.2025.166413 · 2025 · External reference
CaGA nanozymes inhibit oxidative stress and protect mitochondrial function in ulcerative colitis therapy
10.1016/j.actbio.2025.03.003 · 2025 · External reference
TA-V Nanozymes with acid resistance capabilities effectively target and alleviate ulcerative colitis lesions via oral delivery
10.1021/acsami.4c20322 · 2025 · External reference
Neutrophil-macrophage hybrid membrane-coated prussian blue nanozyme for ulcerative colitis treatment and mechanistic insights
10.1186/s12951-025-03123-5 · 2025 · External reference
Targeting macrophage glucose metabolism: polysaccharide-iron nanozyme-mediated reactive oxygen species/iron homeostasis restoration ameliorates inflammatory bowel disease with anemia comorbidity
2025 · External reference
EUK nanozyme-loaded PL&GA coacervate droplets attenuate ulcerative colitis through restoring gut homeostasis and restricting intestinal cell ferroptosis
2025 · External reference
A ROS-responsive nanocarrier co-delivering cerium nanozymes and thalidomide for synergistic ulcerative colitis therapy
2025 · External reference
Genistein-derived ROS-responsive nanoparticles relieve colitis by regulating mucosal homeostasis
10.1021/acsami.1c09215 · 2021 · External reference
Regulation of signaling pathways by metal and metal-doped nanozymes in inflammatory bowel disease: a therapeutic perspective
10.1016/j.nantod.2025.102747 · 2025 · External reference
Pathogenesis guided application of nanozymes in the treatment of inflammatory bowel disease
2025 · External reference
Standardized assays for determining the catalytic activity and kinetics of peroxidase-like nanozymes
10.1038/s41596-018-0001-1 · 2018 · External reference
A bioinspired sulfur–Fe–heme nanozyme with selective peroxidase-like activity for enhanced tumor chemotherapy
10.1038/s41467-024-54868-w · 2024 · External reference
Regulator of oxidative balance: research progress of nanozymes in ROS-related diseases
2025 · External reference
Recent progress of noble metal-based nanozymes: structural engineering and biomedical applications
10.1039/d4nr05514d · 2025 · External reference
Rational design of orally administered cascade nanozyme for inflammatory bowel disease therapy
10.1002/adma.202304967 · 2023 · External reference
Enzyme-mimic activities of RuCo bimetallic nanosheets for inflammatory bowel disease treatment
10.1021/jacs.5c00100 · 2025 · External reference
Recent advances in metal oxide nanozyme-based optical biosensors for food safety assays
10.1016/j.foodchem.2024.139019 · 2024 · External reference
Tailoring metal oxide nanozymes for biomedical applications: trends, limitations, and perceptions
10.1007/s00216-024-05416-4 · 2024 · External reference
Gold nanoparticles-embedded ceria with enhanced antioxidant activities for treating inflammatory bowel disease
2023 · External reference
Immunotherapy strategy for treating inflammatory bowel disease based on a nanozyme/total glucosides of paeony hybrid materials
2025 · External reference
Metal–organic framework-remodeled gut microbiota alleviates colonic inflammation via selective modulation of Roseburia intestinalis
10.1021/acsnano.5c09530 · 2025 · External reference
Microfluidic encapsulated manganese organic frameworks as enzyme mimetics for inflammatory bowel disease treatment
10.1016/j.jcis.2021.09.016 · 2022 · External reference
Advances in polydopamine-based nanoplatforms: antioxidant mechanisms and applications in oxidative stress-mediated diseases
10.1007/s40820-026-02205-9 · 2026 · External reference
Oral metal-free melanin nanozymes for natural and durable targeted treatment of inflammatory bowel disease (IBD)
2023 · External reference
Recent advances in antioxidant carbon dots for biomedical applications
10.1016/j.pmatsci.2026.101706 · 2026 · External reference
Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics
10.1016/j.carbon.2023.01.006 · 2023 · External reference
Dendrobium officinale-derived carbon dots Nanozymes alleviate colitis by orchestrating intestinal mucus-epithelium-immune barriers
10.1002/advs.202512567 · 2025 · External reference
One-pot synthesis of Fe/N-doped hollow carbon nanospheres with multienzyme mimic activities against inflammation
10.1021/acsabm.9b01079 · 2020 · External reference
Small molecule selenium-based glutathione peroxidase 4 mimetic inhibits lipid peroxidation and protects cultured neurons from ferroptosis
10.1016/j.freeradbiomed.2025.06.047 · 2025 · External reference
A novel selenium-based Nanozyme (GSH-se) ameliorates colitis in mice by modulating the Nrf2/Keap1 and GPx4 pathways
2025 · External reference
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
10.1038/s41580-020-0230-3 · 2020 · External reference
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy
10.1186/s13045-023-01512-7 · 2023 · External reference
Reactive oxygen species in hypertension
10.1038/s41569-024-01062-6 · 2025 · External reference
Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells
10.1016/j.immuni.2025.07.012 · 2025 · External reference
Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association
10.1161/res.0000000000000110 · 2016 · External reference
Ex Tenebris lux: illuminating reactive oxygen and nitrogen species with small molecule probes
10.1021/acs.chemrev.3c00892 · 2024 · External reference
Carbon dots for the treatment of inflammatory diseases: an appraisal of in vitro and in vivo studies
10.1155/2023/3076119 · 2023 · External reference
Antioxidant nanozymes as next-generation therapeutics to free radical-mediated inflammatory diseases: a comprehensive review
10.1016/j.ijbiomac.2024.129374 · 2024 · External reference
Biocompatible carbon dots nanozymes as ROS/RNS modulators for ulcerative colitis alleviation by comprehensively orchestrating intestinal homeostasis
2024 · External reference
Disrupted mitochondrial morphology and function exacerbate inflammation in elderly-onset ulcerative colitis
10.1186/s12979-024-00494-5 · 2025 · External reference
CKMT1 deficiency contributes to mitochondrial dysfunction and promotes intestinal epithelial cell apoptosis via reverse electron transfer-derived ROS in colitis
10.1038/s41419-025-07504-4 · 2025 · External reference
Montmorillonite modulates manganese d-band center to enhance cascade reaction activity against inflammatory bowel disease
2025 · External reference
Yeast-inspired orally-administered nanocomposite scavenges oxidative stress and restores gut immune homeostasis for inflammatory bowel disease treatment
10.1021/acsnano.4c18099 · 2025 · External reference
Pathophysiology of inflammatory bowel disease: innate immune system
10.3390/ijms24021526 · 2023 · External reference
Artesunate alleviated murine ulcerative colitis by regulating immune response through inhibiting endoplasmic reticulum stress
2025 · External reference
Host-microbiota interactions in inflammatory bowel disease
10.1038/s41577-019-0268-7 · 2020 · External reference
The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling
10.1038/s41423-021-00810-9 · 2022 · External reference
Nanozyme engineered ROS-tolerant cysteine active-site for upstream deubiquitylation therapy of inflammatory bowel disease
10.1016/j.nantod.2025.102735 · 2025 · External reference
Medicinal plant-derived carbon dots nanozymes ameliorate ulcerative colitis via anti-inflammatory, antioxidant, and gut barrier-protective effects
10.1021/acsami.5c08068 · 2025 · External reference
Mo3Se4 nanoparticle with ROS scavenging and multi-enzyme activity for the treatment of DSS-induced colitis in mice
10.1016/j.redox.2022.102441 · 2022 · External reference
The NRF2/Keap1 pathway as a therapeutic target in inflammatory bowel disease
10.1016/j.molmed.2023.07.008 · 2023 · External reference
The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis
10.3389/fimmu.2023.1200111 · 2023 · External reference
Mechanism of action and therapeutic implications of Nrf2/HO-1 in inflammatory bowel disease
2024 · External reference
Macrophages in intestinal homeostasis and inflammatory bowel disease
10.1038/s41575-023-00769-0 · 2023 · External reference
Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease
10.1186/s40364-024-00612-x · 2024 · External reference
Edible hybrid sporopollenin microspheres with nanozyme for oral treatment of inflammatory bowel disease
10.1021/acsami.5c08167 · 2025 · External reference
L-arginine-modified selenium nanozymes targeting M1 macrophages for oral treatment of ulcerative colitis
2025 · External reference
Zero-valence selenium-enriched prussian blue nanozymes reconstruct intestinal barrier against inflammatory bowel disease via inhibiting ferroptosis and T cells differentiation
10.1002/adhm.202203160 · 2023 · External reference
Nanozyme-enhanced probiotic metabolites targeting tissue-resident memory T cells for inflammatory bowel disease therapy
10.1016/j.cej.2025.165970 · 2025 · External reference
Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway
10.1084/jem.20091154 · 2010 · External reference
Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: pathways, biomarkers, and promising therapies
10.1016/j.cytogfr.2024.10.003 · 2024 · External reference
Polymeric DNase-I nanozymes targeting neutrophil extracellular traps for the treatment of bowel inflammation
10.1186/s40580-024-00414-9 · 2024 · External reference
Myeloperoxidase enzyme activity in feces reflects endoscopic severity in inflammatory bowel disease
10.1093/ibd/izaf109 · 2025 · External reference
Pectinase responsive nanoplatform for oral targeted delivery 5-aminosalicylic acid and zinc coordination driven nanozyme in inflammatory bowel disease treatment
2025 · External reference
Targeting programmed cell death in inflammatory bowel disease through natural products: new insights from molecular mechanisms to targeted therapies
10.1002/ptr.8216 · 2025 · External reference
Role of pyroptosis in inflammatory bowel disease (IBD): from gasdermins to DAMPs
2022 · External reference
Role of pyroptosis in inflammatory bowel disease
10.1016/j.intimp.2025.114619 · 2025 · External reference
DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids
10.1152/ajpgi.00104.2022 · 2022 · External reference
A calcium manganese-based pancatalytic nanozyme as a cell pyroptosis inhibitor for efficient inflammatory bowel disease treatment
10.1039/d5tb01210d · 2025 · External reference
Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis
10.1096/fj.201801417r · 2019 · External reference
Machine learning-assisted high-throughput screening of nanozymes for ulcerative colitis
2025 · External reference
Periodontitis-associated Fusobacterium nucleatum promotes ulcerative colitis by ferroptosis-mediated gut barrier disruption
10.1038/s41522-025-00763-1 · 2025 · External reference
HIF-1α alleviates ferroptosis in ulcerative colitis by regulation of GPX4
10.1038/s41419-025-07883-8 · 2025 · External reference
Oral HMPB/Mn3O4 nanozymes for the treatment of ulcerative colitis via cellular redox balance regulation, gut microbiota modulation, and ferroptosis inhibition
2025 · External reference
Lignans from Schisandra chinensis (Turcz.) Baill ameliorates cognitive impairment in Alzheimer's disease and alleviates ferroptosis by activating the Nrf2/FPN1 signaling pathway and regulating iron levels
10.1016/j.jep.2025.119335 · 2025 · External reference
Melittin-loaded multifunctional nanozyme for ulcerative colitis treatment via enzyme-immunotherapy and ferroptosis inhibition
2025 · External reference
Chlorogenic acid alleviates the intestinal barrier dysfunction and intestinal microbiota disorder induced by cisplatin
10.3389/fmicb.2025.1508891 · 2025 · External reference
Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3
10.1080/19490976.2020.1826748 · 2020 · External reference
Antioxidative nanozyme-fucoidan embedded nanoclay gel mediated mitochondrial energy recovery and bile acid balance against ulcerative colitis
10.1016/j.cej.2025.167765 · 2025 · External reference
Dual-targeting Mn@CeO2 nanozyme-modified probiotic hydrogel microspheres reshape gut homeostasis in inflammatory bowel disease
10.1021/acsnano.5c08999 · 2025 · External reference
Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease
10.1016/j.jcmgh.2017.03.007 · 2017 · External reference
Epithelial neutrophil localization and tight junction claudin-2 expression are innovative outcome predictors in inflammatory bowel disease
10.1002/ueg2.12677 · 2024 · External reference
Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy
10.3748/wjg.14.1972 · 2008 · External reference
A microalgae-probiotic-nanozyme robot for alleviating intestinal inflammation and microbiota dysbiosis
10.1002/adma.202508754 · 2025 · External reference
Incorporating zinc coordination driven nanozyme into chitosan and hyaluronic acid based nanoplatform for scavenging H2S/ROS in managing inflammatory bowel disease
10.1016/j.carbpol.2025.123501 · 2025 · External reference
Bi2O2Se nanosheets coated with rosmarinic acid for colon-targeted treatment of inflammatory bowel disease
10.1016/j.cej.2025.160230 · 2025 · External reference
Manganese oxide nanozyme-loaded CO-releasing halloysite nanotubes for remodeling colonic immune, microbiota, and intestinal barrier homeostasis with concurrent pain relief in ulcerative colitis
2026 · External reference
An anti-miR-301a and zinc coordination driven nanozyme loaded in nanoparticle for oral therapy of inflammatory bowel disease based on colitis microenvironment regulation
10.1016/j.cej.2025.161997 · 2025 · External reference
Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease
10.1186/s12951-024-02749-1 · 2024 · External reference
Achievements in thermosensitive gelling systems for rectal administration
10.3390/ijms22115500 · 2021 · External reference
Mucoadhesive and thermosensitive Bletilla striata polysaccharide/chitosan hydrogel loaded nanoparticles for rectal drug delivery in ulcerative colitis
10.1016/j.ijbiomac.2023.127761 · 2024 · External reference
Adhesive thermosensitive polydopamine hydrogel containing Mn3O4 anchored halloysite clay for treatment of ulcerative colitis
10.1016/j.jcis.2024.12.020 · 2025 · External reference
An olsalazine-loaded hollow mesoporous Prussian blue/polydopamine nanozyme alleviates anxiety/depression-like behavior and enhances brain neural activity in colitis mice
10.1021/acsami.5c18137 · 2025 · External reference
Near-infrared-IIb fluorescent nanozymes with surface charge flipping ability for imaging-guided therapy of inflammatory bowel disease
10.1021/acsnano.5c06179 · 2025 · External reference
Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract
10.1038/s41575-022-00685-9 · 2023 · External reference
Bionic regulators break the ecological niche of pathogenic bacteria for modulating dysregulated microbiome in colitis
10.1002/adma.202204650 · 2022 · External reference
Precisely edited gut microbiota by tungsten-doped prussian blue nanoparticles for the treatment of inflammatory bowel disease
10.1016/j.jconrel.2025.113755 · 2025 · External reference
“Precision-guided killer” engineered phage for combating Carbapenem-resistant Klebsiella pneumoniae induced inflammatory bowel disease
10.1002/adfm.202500754 · 2025 · External reference
Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China
10.1016/j.jinf.2015.07.010 · 2015 · External reference
A droplet microfluidic-derived pathological microenvironment-activated spore nanozyme device for the precise regulation and treatment of colitis
10.1021/acsnano.5c04040 · 2025 · External reference
“Three-birds, one-stone” biomimetic nanozyme system based on oxygen vacancy structure-regulated cascade reaction for inflammatory bowel disease
2025 · External reference
Orally biomimetic metal-phenolic nanozyme with quadruple safeguards for intestinal homeostasis to ameliorate ulcerative colitis
10.1186/s12951-024-02802-z · 2024 · External reference
Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
2024 · External reference
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system
10.1016/j.addr.2024.115275 · 2024 · External reference
Nanozyme-functionalized microalgal biohybrid microrobots in inflammatory bowel disease treatment
10.1016/j.biomaterials.2025.123231 · 2025 · External reference
NIR-controlled photothermal intelligent nanozyme synergizes catalysis and gas therapy for multidimensional treatment of inflammatory bowel disease
10.1186/s12951-025-03878-x · 2025 · External reference
An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease
2024 · External reference
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
10.1186/s12951-023-01770-0 · 2023 · External reference
Oral pyroptosis nanoinhibitor for the treatment of inflammatory bowel disease
10.1007/s12274-023-5969-3 · 2023 · External reference
Orally administered functional polyphenol-nanozyme-armored probiotics for enhanced amelioration of intestinal inflammation and microbiota dysbiosis
2025 · External reference
Aurozyme: a revolutionary nanozyme in colitis, switching peroxidase-like to catalase-like activity
10.1002/smll.202370339 · 2023 · External reference
Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice
10.3389/fchem.2022.969962 · 2022 · External reference
Ligand-targeted Ag9 cluster self-Cascade antioxidants for enhanced reactive oxygen species clearance in the treatment of inflammatory bowel disease
10.1021/acs.nanolett.4c06440 · 2025 · External reference
Multifunctional two-dimensional Bi2Se3 nanodiscs for anti-inflammatory therapy of inflammatory bowel diseases
10.1016/j.actbio.2023.02.016 · 2023 · External reference
Multifunctional double-loaded oral nanoplatform for computed tomography imaging-guided and integrated treatment of inflammatory bowel disease
10.1021/acsnano.4c18865 · 2025 · External reference
An orally administered CeO2@montmorillonite nanozyme targets inflammation for inflammatory bowel disease therapy
10.1002/adfm.202004692 · 2020 · External reference
Oral administration of nanozyme-armed probiotic Escherichia coli Nissle 1917 with ROS scavenging for inflammatory bowel disease therapy
10.1016/j.cej.2025.164949 · 2025 · External reference
Polydopamine modified ceria nanorods alleviate inflammation in colitis by scavenging ROS and regulating macrophage M2 polarization
10.2147/ijn.s416049 · 2023 · External reference
Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome
10.1016/j.biomaterials.2024.122822 · 2025 · External reference
Orally administrated inulin-modified nanozymes for CT-guided IBD theranostics
10.2147/ijn.s497558 · 2025 · External reference
Sulfasalazine-loaded copper-tannic acid coordination nanozyme enables ROS scavenging and immunomodulation for inflammatory bowel disease therapy
10.1002/adhm.202403738 · 2025 · External reference
Cu,Zn,I-doped carbon dots with boosted triple antioxidant nanozyme activity for treatment of DSS-induced colitis
10.1021/acsami.4c03627 · 2024 · External reference
Orally deliverable Iron-ceria nanotablets for treatment of inflammatory bowel disease
2025 · External reference
CT imaging of and therapy for inflammatory bowel disease via low molecular weight dextran coated ceria nanoparticles
10.1039/d4nr04994b · 2025 · External reference
Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy
10.1186/s12951-024-02702-2 · 2024 · External reference
Targeted no-releasing L-arginine-induced hesperetin self-assembled nanoparticles for ulcerative colitis intervention
10.1016/j.actbio.2024.10.037 · 2024 · External reference
A valence-engineered self-cascading antioxidant nanozyme for the therapy of inflammatory bowel disease
2022 · External reference
Mn3O4 Nanozyme loaded thermosensitive PDLLA-PEG-PDLLA hydrogels for the treatment of inflammatory bowel disease
10.1021/acsami.3c03332 · 2023 · External reference
MnNi@PVP nanoenzyme based on regulating inflammation and immune homeostasis for the therapy of inflammatory bowel disease
10.1021/acsami.4c11100 · 2024 · External reference
Catalytically proficient ceria nanodots supported on redox-active mesoporous hosts for treatment of inflammatory bowel disease via efficient ROS scavenging
10.1039/d3tb01602a · 2023 · External reference
Construction of pH-dependent nanozymes with oxygen vacancies as the high-efficient reactive oxygen species scavenger for oral-administrated anti-inflammatory therapy
10.1002/adhm.202101618 · 2021 · External reference
Development of Akkermansia muciniphila membrane-coated mesoporous silica nanoparticles with a cerium oxide core for inflammatory bowel disease treatment
2025 · External reference
Macrophage-derived extracellular vesicles-coated palladium nanoformulations modulate inflammatory and immune homeostasis for targeting therapy of ulcerative colitis
10.1002/advs.202304002 · 2023 · External reference
CO-releasing polyoxometalates nanozyme with gut mucosal immunity and microbiota homeostasis remodeling effects for restoring intestinal barrier integrity
2025 · External reference
Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease
10.1016/j.jconrel.2024.07.064 · 2024 · External reference
2D is better: engineering polydopamine into cationic nanosheets to enhance anti-inflammatory capability
2024 · External reference
Polydopamine-mediated biointerfacial nanozyme as probiotic protective coating for IBD therapy
10.1016/j.ijbiomac.2025.142699 · 2025 · External reference
Prussian blue nanozyme with multienzyme activity reduces colitis in mice
10.1021/acsami.8b10345 · 2018 · External reference
Engineered procyanidin-Fe nanoparticle alleviates intestinal inflammation through scavenging ROS and altering gut microbiome in colitis mice
10.3389/fchem.2023.1089775 · 2023 · External reference
Somatostatin and mannooligosaccharide modified selenium nanoparticles with dual-targeting for ulcerative colitis treatment
10.1021/acsnano.5c00355 · 2025 · External reference
Orally deliverable microalgal-based carrier with selenium nanozymes for alleviation of inflammatory bowel disease
10.1021/acsami.4c08020 · 2024 · External reference
Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy
10.1016/j.matdes.2022.111465 · 2023 · External reference
W-GA nanodots restore intestinal barrier functions by regulating flora disturbance and relieving excessive oxidative stress to alleviate colitis
10.1016/j.actbio.2024.05.030 · 2024 · External reference
Programmed micro-nano hierarchical microspheres for the regulation of gut immunity
10.1016/j.cej.2025.159446 · 2025 · External reference
Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species
10.1016/j.actbio.2024.02.015 · 2024 · External reference
The progression of inorganic nanoparticles and natural products for inflammatory bowel disease
10.1186/s12951-023-02246-x · 2024 · External reference
